RANKL links arterial calcification with osteolysis.
Alexander
M Yvonne
MY
D000818:Animals; D055415:Bone Morphogenetic Protein 4 / Q000378:metabolism; D016723:Bone Remodeling; D002114:Calcinosis / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000378:metabolism* / Q000503:physiopathology; D010014:Osteolysis / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D053244:Osteoprotegerin / Q000378:metabolism; D053245:RANK Ligand / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014652:Vascular Diseases / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy
D055415:Bone Morphogenetic Protein 4; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B